Effect of cross-linking on corneal thickness in patients with corneal edema

Cornea

Volumn 29, Issue 6, 2010, Pages 613-617

  Cordeiro Barbosa, Manuela M V ^a   Barbosa, José Bonifácio ^a   Hirai, Flavio E ^a   Hofling Lima, Ana Luisa ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bullous keratopathy; Corneal edema; Pachymetry; Ross linking

Indexed keywords

COCODAMOL; COLLAGEN; ETORICOXIB; MOXIFLOXACIN; PREDNISOLONE ACETATE;

AGED; ARTICLE; CASE STUDY; CLINICAL ARTICLE; CONGENITAL CORNEA DYSTROPHY; CONTROLLED STUDY; CORNEA EDEMA; CORNEA THICKNESS; CORNEA TRANSPLANTATION; ENDOTHELIAL DYSFUNCTION; FEMALE; GRAFT FAILURE; HUMAN; INTERVENTION STUDY; KERATOPATHY; MALE; OPTICAL COHERENCE TOMOGRAPHY; PATIENT SAFETY; PHOTOTHERAPY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; THERAPY EFFECT; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; COLLAGEN; CORNEA; CORNEAL EDEMA; CORNEAL STROMA; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RIBOFLAVIN; TOMOGRAPHY, OPTICAL COHERENCE; ULTRAVIOLET RAYS; YOUNG ADULT;

EID: 77952950558     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3181c296c2     Document Type: Article

References (25)

1. Meek KM, Boote C. The organization of collagen in the corneal stroma. Exp Eye Res. 2004;78:503-512.
2. Beebe DC. Maintaining transparency: a review of the developmental physiology and pathophysiology of two avascular tissues. Semin Cell Dev Biol. 2008;19:125-133.
3. Adamis AP, Filatov V, Tripathi BJ, et al. Fuchs' endothelial dystrophy of the cornea. Surv Ophthalmol. 1993;38:149-168.
4. Insler MS, Benefield DW, Ross EV. Topical hyperosmolar solutions in the reduction of corneal edema. CLAO J. 1987;13:149-151.
5. Smiddy WE, Hamburg TR, Kracher GP, et al. Therapeutic contact lenses. Ophthalmology. 1990;97:291-295.
6. Cormier G, Brunette I, Boisjoly HM, et al. Anterior stromal punctures for bullous keratopathy. Arch Ophthalmol. 1996;114:654-658.
7. Sonmez B, Kim BT, Aldave AJ. Amniotic membrane transplantation with anterior stromal micropuncture for treatment of painful bullous keratopathy in eyes with poor visual potential. Cornea. 2007;26:227-229.
8. Mejia LF, Santamaria JP, Acosta C. Symptomatic management of postoperative bullous keratopathy with nonpreserved human amniotic membrane. Cornea. 2002;21:342-345.
9. Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003; 135:620-627.
10. Wollensak G, Spoerl E, Seiler T. Stress-strain measurements of human and porcine corneas after riboflavin-ultraviolet-A-induced cross-linking. J Cataract Refract Surg. 2003;29:1780-1785.
11. Gliko-Kabir I, Yagen B, Penhasi A, et al. Low swelling, crosslinked guar and its potential use as colon-specific drug carrier. Pharm Res. 1998;15: 1019-1025.
12. Vandelli MA, Rivasi F, Guerra P, et al. Gelatin microspheres crosslinked with D,L-glyceraldehyde as a potential drug delivery system: preparation, characterisation, in vitro and in vivo studies. Int J Pharm. 2001;215: 175-184.
13. Wollensak G, Aurich H, Pham DT, et al. Hydration behavior of porcine cornea crosslinked with riboflavin and ultraviolet A. J Cataract Refract Surg. 2007;33:516-521.
14. Charulatha V, Rajaram A. Influence of different crosslinking treatments on the physical properties of collagen membranes. Biomaterials. 2003;24: 759-767.
15. Spoerl E, Mrochen M, Sliney D, et al. Safety of UVA-riboflavin cross-linking of the cornea. Cornea. 2007;26:385-389.
16. Maeno A, Naor J, Lee HM, et al. Three decades of corneal transplantation: indications and patient characteristics. Cornea. 2000;19:7-11.
17. Patel NP, Kim T, Rapuano CJ, et al. Indications for and outcomes of repeat penetrating keratoplasty, 1989-1995. Ophthalmology. 2000;107:719-724.
18. Barboza AP, Pereira RC, Garcia CD, et al. Project of cornea donation in the hospital complex of Santa Casa de Porto Alegre, Brazil. Transplant Proc. 2007;39:341-343.
19. Zemba M. [Palliative treatment in bullous keratopathy]. Oftalmologia. 2006;50:23-26.
20. Wollensak G, Aurich H, Wirbelauer C, et al. Potential use of riboflavin/ UVA cross-linking in bullous keratopathy. Ophthalmic Res. 2008;41: 114-117.
21. Wollensak G. Crosslinking treatment of progressive keratoconus: new hope. Curr Opin Ophthalmol. 2006;17:356-360.
22. Ehlers N, Hjortdal J. Riboflavin-ultraviolet light induced cross-linking in endothelial decompensation. Acta Ophthalmol. 2008;86:549-551.
23. Zhao PS, Wong TY, Wong WL, et al. Comparison of central corneal thickness measurements by visante anterior segment optical coherence tomography with ultrasound pachymetry. Am J Ophthalmol. 2007;143: 1047-1049.
24. Prospero Ponce CM, Rocha KM, Smith SD, et al. Central and peripheral corneal thickness measured with optical coherence tomography, Scheimp-flug imaging, and ultrasound pachymetry in normal, keratoconus-suspect, and post-laser in situ keratomileusis eyes. J Cataract Refract Surg. 2009; 35:1055-1062.
25. Leung DY, Lam DK, Yeung BY, et al. Comparison between central corneal thickness measurements by ultrasound pachymetry and optical coherence tomography. Clin Experiment Ophthalmol. 2006;34: 751-754.